Page 2 - லெஸ்லி ரஸ்ஸல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from PR Newswire. The AP news staff was not involved in its creation. Scopus BioPharma Announces Appointment of Additional Directors December 29, 2020 GMT (PRNewsfoto/Scopus BioPharma Inc.) NEW YORK, Dec. 29, 2020 /PRNewswire/ Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. Joshua R. Lamstein, Chairman of Scopus BioPharma, stated, “We are delighted to be in a position to attract prominent industry leaders to our Board. Our new directors are well-recognized for their leadership and accomplishments in the biopharmaceutical, biotechnology and pharmaceutical industries, as well as in public capital markets and corporate governance.”

Israel generalUnited statesFrance generalUnited kingdomCity ofRodd leeds david waldmanScopus biopharmaLesley russellRobertson stephensEli lillyZealand pharmaTruenorth lifesciencesDavida buckelJoshuar lamsteinRaphael rafi hofsteinDavids battleman